Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2012 Aug;43(8):2157-62.
doi: 10.1161/STROKEAHA.112.656173.

Effect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trials

Santiago Palacio  1 , Robert G Hart, Lesly A Pearce, Oscar R Benavente
Affiliations
Meta-Analysis

Effect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trials

Santiago Palacio et al. Stroke. 2012 Aug.

Abstract

Background and purpose: In the Secondary Prevention of Small Subcortical Strokes (SPS3) trial, addition of clopidogrel to aspirin was associated with an unexpected increase in mortality in patients with lacunar strokes. We assessed the effect of the addition of clopidogrel to aspirin on mortality in a meta-analysis of published randomized trials.

Methods: Randomized trials in which clopidogrel was added to aspirin in subjects with vascular disease or vascular risk factors were identified. Trials were restricted to those with a mean follow-up of ≥14 days in which both the combination of aspirin and clopidogrel was tested and mortality was reported.

Results: Twelve trials included 90 934 participants (mean age, 63 years; 70% men; median follow-up, 1 year) with 6849 observed deaths. There was no significant increase in mortality with the combination therapy either in 4 short-term (14 days-3 months; OR, 0.93; 95% CI, 0.87-0.99) or in 7 long-term (>3 months; hazard ratio, 0.97; 95% CI, 0.91-1.04) trials after 1 long-term trial (the SPS3 trial) was excluded because of heterogeneity. Addition of clopidogrel was associated with an increase in fatal hemorrhage (OR, 1.35; 95% CI, 0.97-1.90) and a reduction in myocardial infarction (OR, 0.82; 95% CI, 0.74-0.91).

Conclusions: The addition of clopidogrel to aspirin has no overall effect on mortality. The SPS3 trial results are outliers, possibly because of a lower prevalence of coronary artery ischemia. Addition of clopidogrel to aspirin increases fatal bleeding and reduces myocardial infarction.

Clinical trial registration: URL: http//www.clinicaltrials.gov. Unique identifier: NCT00059306.

PubMed Disclaimer

Figures

Figure
Figure
Meta-analysis of long-term (>3 months) trials.
See this image and copyright information in PMC

References

    1. Benavente O on behalf of the SPS3 Investigators. The Secondary Prevention of Small Subcortical Strokes (SPS3) Trial: Results of the Antiplatelet Intervention. American Heart Association/American Stroke Association International Stroke Conference; February 03, 2012; New Orleans USA. www.strokeconfence.org Session XIII: Plenary Session. Friday, February 3, 2012;11:30.
    1. Johnston C. Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial. NCT00991029. [Access date March 12, 2012]; www.clinicaltrials.gov. Last Updated on January 23, 2012. - PubMed
    1. Mauri L, Kereiakes DJ, Normand SL, Wiviott SD, Cohen DJ, Holmes DR, et al. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions. Am Heart J. 2010;160:1035–1041. - PubMed
    1. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 2004;23:1817. - PubMed
    1. Reviewer Manager (RevMan) (Computer Program) Version 5.0. Copenhagen: The Nordic Cochrane Center. The Cochrane Collaboration; 2008.

Publication types

MeSH terms

Associated data